national stem-cell therapy logo

Revolutionizing Recovery: Harnessing Mesenchymal Stem Cells for Spinal Cord Injury Repair

image representing MSCs repairing a spinal cord injury

Welcome to an exploration of one of the most promising frontiers in medical science: the use of mesenchymal stem cells (MSCs) in the repair of spinal cord injuries. Spinal cord injuries can be devastating, altering lives in an instant and leaving individuals with significant physical challenges. Traditional therapies have made strides in improving outcomes, yet […]

Revolutionary ExoPTEN Therapy: FDA’s New Hope for Spinal Injuries

NurExone

NurExone Biologic Inc., a leading biotechnology company, has recently achieved a significant milestone in the development of treatments for acute spinal cord injuries. The U.S. Food and Drug Administration (FDA) has granted Orphan-Drug Designation (ODD) to the company’s innovative ExoPTEN therapy. This designation is crucial for conditions like acute spinal cord injury, where effective treatments […]